Implantable and Ingestible Biosensors

Implantable and ingestible biosensors are used in medicine and research to monitor patients’ health over extended periods. This review paper focuses on applying these biosensors, their strengths, limitations, stability, and risks. The use of these biosensors has the potential to reduce the costs in the healthcare system and improve the quality of patient treatment. All biosensors mentioned in this review paper allow healthcare workers to monitor patients’ health in real-time and improve their overall quality of life. The ingestible micro bio-electronic device (IMBED) and the My-treatment-medication (MyTMed) have relatively high accuracy and provide information about the gastrointestinal health of the patient. Their high sensitivity is vital for detecting small traces of chemicals in the gastrointestinal tract. Using the ingestible micro-bio-electronic device provides faster detection of gastrointestinal bleeding, especially in gastro intestinal anatomical parts that are hard to reach. My-treatment-medication provides healthcare workers a way to gather information about medication adherence, which was previously based only on the patient's subjective answers. The implantable cardioverter defibrillator and the glucose biosensor prevent heart failure and track the glucose values in the patient's body. Both of them exhibit high accuracy and sensitivity. The irregular heart rate, which can lead to cardiac arrest, can now be monitored and prevented using the implantable cardioverter defibrillator. The glucose biosensor can improve the quality of life of patients who have diabetes.